Analgesics - Brazil | Statista Market Forecast

In Brazil, the revenue generated in the Analgesics market in 2024 amounts to US$1.41bn.
It is projected that the market will experience an annual growth rate of 5.42% (CAGR 2024-2029).
When compared to other countries worldwide, the United States leads in terms of revenue generation, with US$7.24bn in 2024.
Looking at the per capita figures, in 2024, each person in Brazil generates revenues of US$6.46.
Brazil's growing population and increasing healthcare awareness are driving the demand for analgesics in the OTC Pharmaceuticals market.

Definition:
The Analgesics market comprises over-the-counter natural and synthetic non-opioid analgesics (only in approved low doses) like Paracetamol, Ibuprofen, Aspirin, Diclofenac and other pain-relieving preparations. Legislation on opioid analgesics differs from country to country. According to the respective state legislation, legal opioid analgesics are included. In Germany, Austria and Switzerland, for instance, opioid analgesics are only included if they are not limited by the narcotics law and do not require prescription. Analgesics are included in the form of pills, capsules, gels and ointments. Not included are prescription medicines (e.g. morphine), anesthetics and homeopathic remedies. Among the top-selling painkillers are Voltaren, Aspirin, Thomapyrin, Ibuprofen, Dolormin, Paracetamol and ASS. It includes both products which are exclusively sold in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Additional information:
The Analgesics market comprises revenues, average revenue per capita. Sales channels show online and offline revenue. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.

Over-the-counter analgesics (e.g. Aspirin and Paracetamol)
Natural and synthetic agents
In the form of pills, capsules, gels and ointments

Prescription medicines
Homeopathic remedies
Anesthetics

The Analgesics market in Brazil has been experiencing significant growth in recent years, driven by several key factors.

Customer preferences: In Brazil, customers have shown a strong preference for over-the-counter analgesics, which can be purchased without a prescription. This is due to the convenience and accessibility of these products, as well as the relatively low cost compared to prescription medications. Customers also value products that offer fast and effective pain relief, as well as those that are easy to use and have minimal side effects.

Trends in the market: One of the major trends in the Analgesics market in Brazil is the increasing demand for natural and herbal remedies. Customers are becoming more conscious about the ingredients in the products they consume and are seeking alternatives to traditional pharmaceuticals. This trend is driven by a desire for more natural and holistic approaches to healthcare, as well as concerns about potential side effects of synthetic medications.Another trend in the market is the growing popularity of online sales channels. With the rise of e-commerce platforms, customers are increasingly turning to online retailers to purchase their analgesic products. This trend is driven by the convenience and ease of online shopping, as well as the ability to compare prices and read customer reviews before making a purchase.

Local special circumstances: One of the unique factors influencing the Analgesics market in Brazil is the country's large population and high prevalence of chronic pain conditions. Brazil has one of the highest rates of chronic pain in the world, with millions of people suffering from conditions such as arthritis, back pain, and migraines. This creates a significant demand for analgesic products to manage and alleviate pain symptoms.Another special circumstance in Brazil is the country's complex healthcare system. The public healthcare system, known as the Unified Health System (SUS), provides free healthcare services to the entire population. However, due to the high demand and limited resources, there can be long waiting times for medical appointments and access to prescription medications. This has led many Brazilians to seek over-the-counter analgesics as a more immediate and affordable solution for pain relief.

Underlying macroeconomic factors: The Analgesics market in Brazil is also influenced by underlying macroeconomic factors. The country has experienced periods of economic instability and inflation in recent years, which has affected consumer purchasing power. During times of economic downturn, customers may be more likely to opt for lower-cost analgesic products or delay purchases altogether. On the other hand, during periods of economic growth, customers may have more disposable income to spend on healthcare products.In conclusion, the Analgesics market in Brazil is growing due to customer preferences for over-the-counter products, trends towards natural remedies and online sales, as well as local special circumstances such as a high prevalence of chronic pain and a complex healthcare system. The market is also influenced by underlying macroeconomic factors, which can impact consumer purchasing power.

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

The global pharmaceutical industry has experienced significant growth during the past two decades, with revenues totaling around 1.6 trillion U.S. dollars in 2023. With growth like that, the industry's size is now comparable to the gross domestic products (GDPs) of countries like Spain, Mexico, or Australia.